Close Menu

NEW YORK (GenomeWeb) – Natera is aiming to raise $75 million in a follow-on public offering of shares of its common stock, the firm reported after the close of the market on Tuesday. It also expects to grant underwriters a 30-day option to purchase up to an additional $11.25 million worth of common stock.

JP Morgan, Morgan Stanley, and Cowen are acting as joint book-running managers for the offering, which will be made only through a prospectus and related prospectus supplement, copies of which can be obtained from JP Morgan Securities.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.